Nautilus Biotechnology, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
AH CAPITAL MANAGEMENT, L.L.C. | 02/12/2025 | 17.65 M | $29.66 M | 0.00% | 14.07% |
PERCEPTIVE ADVISORS LLC | 02/14/2025 | 12.59 M | $21.16 M | 0.00% | 10.04% |
CERCANO MANAGEMENT LLC | 02/14/2025 | 7.17 M | $12.05 M | 0.00% | 5.72% |
MADRONA VENTURE GROUP, LLC | 02/14/2025 | 6.02 M | $10.12 M | 0.00% | 4.80% |
BLACKROCK, INC. | 02/07/2025 | 3.07 M | $5.16 M | -13.93% | 2.45% |
VANGUARD GROUP INC | 02/11/2025 | 2.78 M | $4.67 M | 0.44% | 2.21% |
COMPREHENSIVE FINANCIAL MANAGEMENT LLC | 02/14/2025 | 2.21 M | $3.71 M | 0.00% | 1.76% |
BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 02/14/2025 | 1.76 M | $2.96 M | -12.05% | 1.40% |
AMAZON COM INC | 02/07/2025 | 1.46 M | $2.45 M | 0.00% | 1.16% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.14 M | $1.92 M | 0.62% | 0.91% |
STATE STREET CORP | 02/14/2025 | 930,531 | $1.56 M | -0.26% | 0.74% |
DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 770,353 | $1.29 M | 11.32% | 0.61% |
TIKVAH MANAGEMENT LLC | 02/13/2025 | 726,895 | $1.22 M | 0.00% | 0.58% |
CLARIUS GROUP, LLC | 01/16/2025 | 636,532 | $1.07 M | 0.00% | 0.51% |
ARCHPOINT INVESTORS | 02/13/2025 | 606,133 | $1.02 M | -1.32% | 0.48% |
NORTHERN TRUST CORP | 02/14/2025 | 474,821 | $797,699 | -6.44% | 0.38% |
MORGAN STANLEY | 02/14/2025 | 393,606 | $661,258 | -1.72% | 0.31% |
WEXFORD CAPITAL LP | 02/14/2025 | 325,239 | $546,402 | 42.43% | 0.26% |
SENTINEL TRUST CO LBA | 02/05/2025 | 255,000 | $428,000 | -19.05% | 0.20% |
ALYESKA INVESTMENT GROUP, L.P. | 02/14/2025 | 253,468 | $425,826 | -42.53% | 0.20% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 250,221 | $420,371 | 61.75% | 0.20% |
CITADEL ADVISORS LLC | 02/14/2025 | 220,220 | $369,970 | 177.57% | 0.18% |
HILLMAN CO | 01/21/2025 | 200,000 | $336,000 | 0.00% | 0.16% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 195,695 | $328,768 | 20.56% | 0.16% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 193,591 | $325,234 | 0.00% | 0.15% |
JPMORGAN CHASE & CO | 02/12/2025 | 145,937 | $245,173 | 309.90% | 0.12% |
BARCLAYS PLC | 02/13/2025 | 125,204 | $210,000 | 17.92% | 0.10% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 115,231 | $193,588 | -16.19% | 0.09% |
JANE STREET GROUP, LLC | 02/14/2025 | 108,545 | $182,356 | 188.06% | 0.09% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 106,697 | $179,251 | 0.00% | 0.09% |
RHUMBLINE ADVISERS | 01/30/2025 | 73,383 | $123,275 | 3.52% | 0.06% |
HSBC HOLDINGS PLC | 02/14/2025 | 55,184 | $92,157 | 182.50% | 0.04% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 49,419 | $83,024 | 37.06% | 0.04% |
UBS GROUP AG | 02/14/2025 | 47,230 | $79,346 | 70.01% | 0.04% |
CI PRIVATE WEALTH, LLC | 02/10/2025 | 45,350 | $76,188 | 0.00% | 0.04% |
CITIGROUP INC | 02/12/2025 | 40,572 | $68,160 | 4.08% | 0.03% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 39,004 | $65,527 | 100.00% | 0.03% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 37,704 | $63,343 | 100.00% | 0.03% |
SIGNATUREFD, LLC | 02/10/2025 | 37,313 | $62,686 | 0.00% | 0.03% |
VANGUARD CAPITAL WEALTH ADVISORS | 02/18/2025 | 31,500 | $52,920 | -10.00% | 0.03% |
BADGLEY PHELPS WEALTH MANAGERS, LLC | 02/11/2025 | 30,000 | $50,400 | 0.00% | 0.02% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 28,896 | $48,545 | 11.00% | 0.02% |
PALUMBO WEALTH MANAGEMENT LLC | 01/30/2025 | 28,475 | $47,838 | 45.38% | 0.02% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 27,878 | $46,835 | 4.56% | 0.02% |
SG AMERICAS SECURITIES, LLC | 01/17/2025 | 27,483 | $46,000 | 56.34% | 0.02% |
SQUAREPOINT OPS LLC | 02/14/2025 | 26,324 | $44,224 | 100.00% | 0.02% |
COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 24,222 | $40,693 | -7.02% | 0.02% |
LAKE STREET ADVISORS GROUP, LLC | 02/04/2025 | 22,762 | $38,240 | 0.00% | 0.02% |
DEUTSCHE BANK AG\ | 02/14/2025 | 22,369 | $37,580 | 0.00% | 0.02% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 21,460 | $36,053 | 0.00% | 0.02% |
Nautilus Biotechnology, Inc. institutional Ownership - FAQ's
During the previous two years, 93 institutional investors and hedge funds held shares of Nautilus Biotechnology, Inc.. The most heavily invested institutionals were:
Elser Financial Planning, Inc: 0
Nelson, Van Denburg & Campbell Wealth Management Group, LLC: 0
Northstar Advisory Group, LLC: 0
Ronald Blue Trust, Inc.: 0
AH Capital Management, L.L.C.: 17.65 M
PERCEPTIVE ADVISORS LLC: 12.59 M
50.90% of Nautilus Biotechnology, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 84.51 M shares in the last 24 months. This purchase volume represents approximately $60.25 M in transactions.